A non-inferiority and GLP-compliant study of broflanilide IRS (VECTRON™ T500), a novel meta-diamide insecticide against Anopheles arabiensis

Overview of attention for article published in Frontiers in Tropical Diseases, January 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Is Anopheles gambiae (sensu stricto), the principal malaria vector in Africa prone to resistance development against new insecticides? Outcomes from laboratory exposure of An. gambiae (s.s.) to sub-lethal concentrations of chlorfenapyr and clothianidin

Article in Current Research in Parasitology and Vector-Borne Diseases (February 2024)

Community evaluation of VECTRON™ T500, a broflanilide insecticide, for indoor residual spraying for malaria vector control in central Benin; a two arm non-inferiority cluster randomised trial

Article in Scientific Reports (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.